BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19047098)

  • 1. Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.
    Goldhoff P; Warrington NM; Limbrick DD; Hope A; Woerner BM; Jackson E; Perry A; Piwnica-Worms D; Rubin JB
    Clin Cancer Res; 2008 Dec; 14(23):7717-25. PubMed ID: 19047098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model.
    Ramezani S; Vousooghi N; Ramezani Kapourchali F; Yousefzadeh-Chabok S; Reihanian Z; Alizadeh AM; Khodayari S; Khodayari H
    Life Sci; 2019 Dec; 239():116880. PubMed ID: 31678282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
    Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
    Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
    Campos-Toimil M; Keravis T; Orallo F; Takeda K; Lugnier C
    Br J Pharmacol; 2008 May; 154(1):82-92. PubMed ID: 18311187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.
    Schmidt AL; de Farias CB; Abujamra AL; Kapczinski F; Schwartsmann G; Brunetto AL; Roesler R
    J Mol Neurosci; 2010 Mar; 40(3):303-10. PubMed ID: 19642024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
    Hu W; Lu T; Chen A; Huang Y; Hansen R; Chandler LJ; Zhang HT
    Psychopharmacology (Berl); 2011 Nov; 218(2):331-9. PubMed ID: 21509503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
    Cherry JA; Thompson BE; Pho V
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Brain Res; 2006 Jun; 1096(1):104-12. PubMed ID: 16730340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.
    Moroz MA; Huang R; Kochetkov T; Shi W; Thaler H; de Stanchina E; Gamez I; Ryan RP; Blasberg RG
    Clin Cancer Res; 2011 May; 17(10):3282-92. PubMed ID: 21385926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase-4 inhibition and brain tumor growth.
    Schmidt AL; de Farias CB; Abujamra AL; Brunetto AL; Schwartsmann G; Roesler R
    Clin Cancer Res; 2009 May; 15(9):3238; author reply 3238-9. PubMed ID: 19406836
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
    Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
    J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal cultures.
    Ye Y; Jackson K; Houslay MD; Chandler LJ; O'Donnell JM
    Brain Res Dev Brain Res; 2001 Sep; 130(1):115-21. PubMed ID: 11557100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain.
    Ye Y; Conti M; Houslay MD; Farooqui SM; Chen M; O'Donnell JM
    J Neurochem; 1997 Dec; 69(6):2397-404. PubMed ID: 9375671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
    J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation.
    Nguyen SA; Stechishin OD; Luchman HA; Lun XQ; Senger DL; Robbins SM; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Sep; 20(18):4894-903. PubMed ID: 25078279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway.
    Li Q; Peng Y; Fan L; Xu H; He P; Cao S; Li J; Chen T; Ruan W; Chen G
    Biomed Pharmacother; 2018 Mar; 99():947-955. PubMed ID: 29710495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.